Ibrance 00069-0189
Generic: Palbociclib
Product NDC
00069-0189- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 3, 2015
- Listing Expires
- December 31, 2027
- Application
- NDA207103
Need to source Ibrance? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Palbociclib | 125 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Cytochrome P450 3A Inhibitors [MoA]Kinase Inhibitor [EPC]
Packaging Options(1)
21 CAPSULE in 1 BOTTLE (0069-0189-21)